A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.

According to Vesprini, the most common problem most men experience is that the prostate continues growing. While it might be ...

This partnership unites the expertise of KFSHRC’s Urology Department with BCRC’s research capabilities to advance ...

For men first treated with radiotherapy, the risk of such complications that was almost three times that of untreated men and this group also had three times the risk of a bladder cancer diagnosis.

This project aims to bring cutting-edge molecular diagnostics to Saudi Arabia using a 23-gene panel to detect key genetic ...

THURSDAY, Nov. 7, 2024 (HealthDay News) -- Men who undergo prostate cancer treatment face a greatly increased risk of ...

Prostate cancer symptoms can be hard to spot, but there are certain signs to look out for when you go to the toilet. Here's ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia has entered a five-year partnership with the ...

in muscle-invasive bladder cancer, MIBC. The publication is now available online and will be in a future print edition of Nature Medicine. The results were also presented at the Society for ...

Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...